Female Health Co (NASDAQ:FHCO) Director Harry Fisch bought 10,000 shares of Female Health stock in a transaction that occurred on Wednesday, May 24th. The stock was purchased at an average cost of $1.10 per share, for a total transaction of $11,000.00. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

Harry Fisch also recently made the following trade(s):

  • On Monday, May 22nd, Harry Fisch acquired 24,750 shares of Female Health stock. The shares were bought at an average cost of $1.02 per share, for a total transaction of $25,245.00.

Shares of Female Health Co (NASDAQ:FHCO) traded up 6.67% on Wednesday, hitting $1.12. The stock had a trading volume of 190,788 shares. Female Health Co has a 12 month low of $0.72 and a 12 month high of $1.65. The stock’s market cap is $35.10 million. The company has a 50 day moving average price of $1.00 and a 200-day moving average price of $1.02.

Female Health (NASDAQ:FHCO) last posted its earnings results on Tuesday, May 9th. The company reported ($0.06) earnings per share for the quarter. Female Health had a negative return on equity of 7.20% and a negative net margin of 14.65%. The business had revenue of $2.41 million during the quarter. On average, equities research analysts anticipate that Female Health Co will post $0.15 earnings per share for the current year.

Insider Buying and Selling by Quarter for Female Health (NASDAQ:FHCO)

WARNING: “Insider Buying: Female Health Co (FHCO) Director Purchases 10,000 Shares of Stock” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/05/24/insider-buying-female-health-co-fhco-director-purchases-10000-shares-of-stock.html.

Female Health Company Profile

The Female Health Company is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.

12 Month Chart for NASDAQ:FHCO

Receive News & Ratings for Female Health Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Female Health Co and related companies with MarketBeat.com's FREE daily email newsletter.